Plasminogen activation has been found to be positively correlated with tumor malignancy [10], and, in accordance, increased serum levels of uPA and uPAR have been positively correlated with poor prognosis in patients with prostate and breast cancer [11], [12]. The gene discussed is PLAU; the disease is neoplasm.